pharmaphorum Podcast
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

October 15, 2021

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and communications.

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

October 4, 2021

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.

Virtual engagement and collaborations: the pharmaphorum podcast

Virtual engagement and collaborations: the pharmaphorum podcast

September 22, 2021

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthcare sector has brought huge changes to the way pharma engages healthcare professionals.

Biotech Insight podcast: Overcoming planning challenges in oncology

Biotech Insight podcast: Overcoming planning challenges in oncology

September 8, 2021

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies face, with a particular focus on oncology.

Vertex senior country manager Nicola Massey: the pharmaphorum podcast

Vertex senior country manager Nicola Massey: the pharmaphorum podcast

August 23, 2021

In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.

Regenerative medicine and COVID: the pharmaphorum podcast

Regenerative medicine and COVID: the pharmaphorum podcast

August 13, 2021

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine.

Pharmacy and clinical research: the pharmaphorum podcast

Pharmacy and clinical research: the pharmaphorum podcast

June 30, 2021

In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.

The US-based company was founded in 2019 and is on a mission to bring the practice of pharmacy into clinical research. 

Pharma’s post-COVID prospects: the pharmaphorum podcast

Pharma’s post-COVID prospects: the pharmaphorum podcast

May 28, 2021

In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season.

Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast

Galapagos UK’s Michael Smyth on COVID and RNA-based tech: the pharmaphorum podcast

April 30, 2021

Episode 35 of the pharmaphorum podcast heard from Michael Smyth about Galapagos UK and joining the company as medical director just as COVID-19 hit.

Big data and cell therapy development: the pharmaphorum podcast

Big data and cell therapy development: the pharmaphorum podcast

April 20, 2021

In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr. Darrin Disley, CEO of UK biotech Mogrify

GSK on COVID and vaccine development: the pharmaphorum podcast

GSK on COVID and vaccine development: the pharmaphorum podcast

March 31, 2021

In the latest episode of the podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandemic.

The meaning of digital innovation: the pharmaphorum podcast

The meaning of digital innovation: the pharmaphorum podcast

March 23, 2021

This instalment of the podcast considers the meaning of digital innovation, both in pharma and outside the industry, and features digital transformation leader Edwin Erckens.

New ways to treat COVID: the pharmaphorum podcast

New ways to treat COVID: the pharmaphorum podcast

March 12, 2021

In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldberg about the potential for new COVID-19 therapeutics to help fight the pandemic and treat patients in the years to come.

The Alderley Park Discovery Podcast: The journey to accessing science funding and investment

The Alderley Park Discovery Podcast: The journey to accessing science funding and investment

March 8, 2021

Episode 3 of the Alderley Park Discovery Podcast covers how to successfully access life science funding and investment, highlighting a range of ways companies can attract investors.

In this instalment, Dominic Tyer is joined by Kinomica CEO Jane Theaker, BioCity investment director Claire Brown, Redx Pharma CEO Lisa Anson and Dr Kath Mackay, managing director at Bruntwood SciTech - Alderley Park.

Roche on COVID healthcare and testing: the pharmaphorum podcast

Roche on COVID healthcare and testing: the pharmaphorum podcast

February 26, 2021

For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.

A former NHS doctor, he noted how stressful and draining some days can be when working at healthcare’s frontline - even in normal times, and that the current fight against the pandemic brings little respite to staff.

Podbean App

Play this podcast on Podbean App